158 related articles for article (PubMed ID: 15986446)
61. Molecular dissection of isolated disease features in mosaic neurofibromatosis type 1.
Maertens O; De Schepper S; Vandesompele J; Brems H; Heyns I; Janssens S; Speleman F; Legius E; Messiaen L
Am J Hum Genet; 2007 Aug; 81(2):243-51. PubMed ID: 17668375
[TBL] [Abstract][Full Text] [Related]
62. Uncommon Alu-mediated NF1 microdeletion with a breakpoint inside the NF1 gene.
Gervasini C; Venturin M; Orzan F; Friso A; Clementi M; Tenconi R; Larizza L; Riva P
Genomics; 2005 Feb; 85(2):273-9. PubMed ID: 15676286
[TBL] [Abstract][Full Text] [Related]
63. Molecular characterization and gene content of breakpoint boundaries in patients with neurofibromatosis type 1 with 17q11.2 microdeletions.
Jenne DE; Tinschert S; Reimann H; Lasinger W; Thiel G; Hameister H; Kehrer-Sawatzki H
Am J Hum Genet; 2001 Sep; 69(3):516-27. PubMed ID: 11468690
[TBL] [Abstract][Full Text] [Related]
64. Solitary epicranial neurofibroma with NF1-related germline mutation: case report.
Sugiyama N; Tsutsumi S; Akiba C; Nakanishi H; Ogino I; Yasumoto Y; Arai H; Ito M
Neurol Med Chir (Tokyo); 2014; 54(4):310-3. PubMed ID: 24140765
[TBL] [Abstract][Full Text] [Related]
65. Biallelic inactivation of TP53 rarely contributes to the development of malignant peripheral nerve sheath tumors.
Lothe RA; Smith-Sørensen B; Hektoen M; Stenwig AE; Mandahl N; Saeter G; Mertens F
Genes Chromosomes Cancer; 2001 Feb; 30(2):202-6. PubMed ID: 11135438
[TBL] [Abstract][Full Text] [Related]
66. Molecular cytogenetic characterization of variant Philadelphia translocations in chronic myeloid leukemia: genesis and deletion of derivative chromosome 9.
Bennour A; Sennana H; Laatiri MA; Elloumi M; Khelif A; Saad A
Cancer Genet Cytogenet; 2009 Oct; 194(1):30-7. PubMed ID: 19737651
[TBL] [Abstract][Full Text] [Related]
67. Neurofibromatosis-1 gene deletions and mutations in de novo adult acute myeloid leukemia.
Boudry-Labis E; Roche-Lestienne C; Nibourel O; Boissel N; Terre C; Perot C; Eclache V; Gachard N; Tigaud I; Plessis G; Cuccuini W; Geffroy S; Villenet C; Figeac M; Leprêtre F; Renneville A; Cheok M; Soulier J; Dombret H; Preudhomme C;
Am J Hematol; 2013 Apr; 88(4):306-11. PubMed ID: 23460398
[TBL] [Abstract][Full Text] [Related]
68. Alterations at chromosome 17 loci in peripheral nerve sheath tumors.
Lothe RA; Slettan A; Saeter G; Brøgger A; Børresen AL; Nesland JM
J Neuropathol Exp Neurol; 1995 Jan; 54(1):65-73. PubMed ID: 7815081
[TBL] [Abstract][Full Text] [Related]
69. Interphase FISH, the structure of reciprocal translocation chromosomes and physical mapping studies rule out the duplication of the NF1 gene at 17q11.2. A reply.
Kehrer-Sawatzki H; Messiaen L
Hum Genet; 2003 Jul; 113(2):188-90. PubMed ID: 12698359
[No Abstract] [Full Text] [Related]
70. Neurofibroma-associated growth factors activate a distinct signaling network to alter the function of neurofibromin-deficient endothelial cells.
Munchhof AM; Li F; White HA; Mead LE; Krier TR; Fenoglio A; Li X; Yuan J; Yang FC; Ingram DA
Hum Mol Genet; 2006 Jun; 15(11):1858-69. PubMed ID: 16648142
[TBL] [Abstract][Full Text] [Related]
71. Monosomy 7 myelodysplastic syndrome and other second malignant neoplasms in children with neurofibromatosis type 1.
Maris JM; Wiersma SR; Mahgoub N; Thompson P; Geyer RJ; Hurwitz CG; Lange BJ; Shannon KM
Cancer; 1997 Apr; 79(7):1438-46. PubMed ID: 9083167
[TBL] [Abstract][Full Text] [Related]
72. Do non-pathogenic variants of DNA mismatch repair genes modify neurofibroma load in neurofibromatosis type 1?
Harder A
Childs Nerv Syst; 2022 Apr; 38(4):705-713. PubMed ID: 34997843
[TBL] [Abstract][Full Text] [Related]
73. How to Distinguish Solitary Neurofibroma From Neurofibromatosis Type 1.
Guo C; Zhou L; Sun Y; Hu X
J Craniofac Surg; 2022 May; 33(3):889-891. PubMed ID: 35727670
[TBL] [Abstract][Full Text] [Related]
74. Thinking beyond the tumor cell: Nf1 haploinsufficiency in the tumor environment.
McLaughlin ME; Jacks T
Cancer Cell; 2002 Jun; 1(5):408-10. PubMed ID: 12124168
[TBL] [Abstract][Full Text] [Related]
75. Identification and characterization of NF1-related loci on human chromosomes 22, 14 and 2.
Hulsebos TJ; Bijleveld EH; Riegman PH; Smink LJ; Dunham I
Hum Genet; 1996 Jul; 98(1):7-11. PubMed ID: 8682511
[TBL] [Abstract][Full Text] [Related]
76. Molecular characterization of a 17q11.2 translocation in a malignant schwannoma cell line.
Reynolds JE; Fletcher JA; Lytle CH; Nie L; Morton CC; Diehl SR
Hum Genet; 1992 Dec; 90(4):450-6. PubMed ID: 1483704
[TBL] [Abstract][Full Text] [Related]
77. New insights into the neurofibroma tumor cells of origin.
Li S; Chen Z; Le LQ
Neurooncol Adv; 2020 Jul; 2(Suppl 1):i13-i22. PubMed ID: 32642729
[TBL] [Abstract][Full Text] [Related]
78. Clinical diagnosis of neurofibromatosis type I in multiple family members due to cosegregation of a unique balanced translocation with disruption of the NF1 locus: Testing considerations for accurate diagnosis.
Smith RB; Solem EP; Metz EC; Wheeler FC; Phillips JA; Yenamandra A
Am J Med Genet A; 2021 Apr; 185(4):1222-1227. PubMed ID: 33415784
[TBL] [Abstract][Full Text] [Related]
79. Precise localization of NF1 to 17q11.2 by balanced translocation.
Ledbetter DH; Rich DC; O'Connell P; Leppert M; Carey JC
Am J Hum Genet; 1989 Jan; 44(1):20-4. PubMed ID: 2491776
[TBL] [Abstract][Full Text] [Related]
80. Physical mapping of the von Recklinghausen neurofibromatosis region on chromosome 17.
Fountain JW; Wallace MR; Brereton AM; O'Connell P; White RL; Rich DC; Ledbetter DH; Leach RJ; Fournier RE; Menon AG
Am J Hum Genet; 1989 Jan; 44(1):58-67. PubMed ID: 2491783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
